Economic Impact of The Addition of Axitinib as a Second Line Treatment for Metastatic Renal cell Carcinoma in the Ecuatorian Public Heathcare Sector
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1134
https://www.valueinhealthjournal.com/article/S1098-3015(15)01191-2/fulltext
Title :
Economic Impact of The Addition of Axitinib as a Second Line Treatment for Metastatic Renal cell Carcinoma in the Ecuatorian Public Heathcare Sector
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01191-2&doi=10.1016/j.jval.2015.03.1134
First page :
A195
Section Title :
Cancer
Open access? :
No
Section Order :
584